Dihydrocodeine: safety concerns

Acute Generalized Exanthematous Pustulosis Caused by Dihydrocodeine Phosphate in a Patient With Psoriasis Vulgaris and a HeterozygousIL36RNMutation

(2015) Noriaki Nakai et al.   JAMA Dermatology

A randomized, double-blind, double-dummy comparison of short- and long-acting dihydrocodeine in chronic non-malignant pain

(2013) Line Pedersen et al.   PAIN

Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC

(2012) Augusto Caraceni et al.   LANCET ONCOLOGY

Deaths of opiate/opioid misusers involving dihydrocodeine, UK, 1997-2007

(2011) Giuliano Zamparutti et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Dihydrocodeine as an Opioid Analgesic for the Treatment of Moderate to Severe Chronic Pain

(2010) Wojciech Leppert   CURRENT DRUG METABOLISM

The impact of tramadol and dihydrocodeine treatment on quality of life of patients with cancer pain

(2010) W. Leppert et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE